000 | 01993 a2200553 4500 | ||
---|---|---|---|
005 | 20250515095720.0 | ||
264 | 0 | _c20080502 | |
008 | 200805s 0 0 eng d | ||
022 | _a0014-4886 | ||
024 | 7 |
_a10.1016/j.expneurol.2007.10.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcCoy, Melissa K | |
245 | 0 | 0 |
_aAutologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease. _h[electronic resource] |
260 |
_bExperimental neurology _cMar 2008 |
||
300 |
_a14-29 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdipose Tissue _xcytology |
650 | 0 | 4 |
_aAdrenergic Agents _xtoxicity |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCD11b Antigen _xmetabolism |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 |
_aCell Transplantation _xmethods |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
650 | 0 | 4 |
_aNeurons _xmetabolism |
650 | 0 | 4 |
_aOxidopamine _xtoxicity |
650 | 0 | 4 |
_aParkinson Disease _xetiology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aStromal Cells _xtransplantation |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransplantation, Autologous _xmethods |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aMartinez, Terina N | |
700 | 1 | _aRuhn, Kelly A | |
700 | 1 | _aWrage, Philip C | |
700 | 1 | _aKeefer, Edward W | |
700 | 1 | _aBotterman, Barry R | |
700 | 1 | _aTansey, Keith E | |
700 | 1 | _aTansey, MalĂș G | |
773 | 0 |
_tExperimental neurology _gvol. 210 _gno. 1 _gp. 14-29 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2007.10.011 _zAvailable from publisher's website |
999 |
_c17575274 _d17575274 |